Supreme Court agrees to hear landmark Merck Fosamax case

A key case for the product liability (re)insurance market is set to be tested at the highest level by the US legal system after the Supreme Court agreed on 28 June to hear a ruling over Merck’s drug Fosamax.

To unlock article: